Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration The COMPLETE Study

Overview of attention for article published in Ophthalmology, November 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

patent: 8 patents

Readers on

mendeley: 244 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

Multimodal geographic atrophy lesion segmentation

Grant US-12657717-B2

United States of America

16 Jun 2026

Protection of cells from degeneration and treatment of geographic atrophy

Grant US-11883409-B2

United States of America

30 Jan 2024

Protection of cells from degeneration and treatment of geographic atrophy

Grant US-11730743-B2

United States of America

22 Aug 2023

USE OF COMPLEMENT FACTOR D INHIBITOR FOR TREATMENT OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-R…

Application WO-2022251543-A1

World Intellectual Property Organisation (WIPO)

01 Dec 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.